ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.70
0.13%
Dow Jones
38,884.26
0.08%
US Dollar vs MXN
16.9323
0.15%
Brent Oil
82.695
-0.21%
Bitcoin
62,781.68
0.72%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Selecta Biosciences Inc (SELB)

  7. Selecta Biosciences Inc (SELB) Noticias

SELB Selecta Biosciences Inc

0.8812
0.00 (0.00%)
06 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Selecta Biosciences Inc SELB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 0.8812 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.8812 0.8812
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/4/202408:09EDGAR2Form DEF 14A - Other definitive proxy statements
26/4/202406:57EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/4/202405:25EDGAR2Form 8-K - Current report
19/4/202415:49EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/4/202420:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/4/202420:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/4/202420:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/4/202420:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/4/202420:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/4/202415:29EDGAR2Form SC 13D/A - General statement of acquisition of..
10/4/202415:25EDGAR2Form SC 13D/A - General statement of acquisition of..
10/4/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/4/202406:00EDGAR2Form 8-K - Current report
01/4/202415:32EDGAR2Form 8-K - Current report
28/3/202416:00EDGAR2Form 8-K - Current report
14/3/202406:55EDGAR2Form 8-K - Current report
07/3/202406:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202406:06EDGAR2Form 8-K - Current report
05/3/202406:05EDGAR2Form 8-K - Current report
14/2/202416:27EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/2/202415:42EDGAR2Form DEF 14A - Other definitive proxy statements
14/2/202411:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202415:30EDGAR2Form PRE 14A - Other preliminary proxy statements
23/1/202415:05EDGAR2Form 8-K/A - Current report: [Amend]
19/1/202415:12EDGAR2Form 8-K - Current report
12/1/202415:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202407:45EDGAR2Form 8-K - Current report
08/1/202406:10GLOBECartesian Therapeutics Highlights Progress and 2024..
08/1/202406:00GLOBECartesian Therapeutics Announces Positive Long-Term..
04/1/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202315:28EDGAR2Form 8-A12G - Registration of securities [Section 12(g)]
04/12/202315:39EDGAR2Form D/A - Notice of Exempt Offering of Securities: [Amend]
01/12/202307:31EDGAR2Form S-3/A - Registration statement under Securities Act of..
27/11/202315:18EDGAR2Form 8-K - Current report
22/11/202315:39EDGAR2Form SC 13D - General statement of acquisition of beneficial..
22/11/202315:38EDGAR2Form SC 13D - General statement of acquisition of beneficial..
15/11/202316:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202316:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202316:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202316:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202315:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202315:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
SELB
Selecta Biosciences
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados